Skip to content
PeptideAgent

Clinics in Alabama

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Alabama law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Alabama at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Alabama

No verified clinics serving Alabama are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Alabama

Yes, with conditions. An Alabama resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Alabama-licensed physician, including through telehealth under the 2022 telehealth statute (Code of Alabama sections 34-24-701 through 34-24-707), and can obtain a compounded peptide only when it is eligible under federal 503A rules and dispensed by an Alabama-permitted pharmacy or a nonresident pharmacy registered with the Alabama State Board of Pharmacy. Alabama physicians must see a telehealth patient in person after four telehealth visits for the same unresolved condition in 12 months, and the Board of Pharmacy has taken a public position against semaglutide salt forms in compounding. [1] [2] [3] [4] [5] [6] [7] [8] [10] [13]

Compounded GLP-1 access in Alabama

Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient-specific needs since the FDA shortage declarations ended in 2025, and Alabama is one of the states whose Board of Pharmacy publicly warned pharmacies about semaglutide copies and salt forms. The Board of Medical Examiners has also published fraud alerts about counterfeit Ozempic and unlicensed sellers. [3] [8] [9] [11]

Research use only sellers in Alabama

Selling prescription drugs to Alabama consumers requires a Board of Pharmacy permit, and "research use only" peptides sold for human injection are unapproved new drugs under 21 U.S.C. 331 and 355 regardless of labeling. The Alabama Board of Medical Examiners has warned the public about unlicensed sellers of semaglutide and tirzepatide, and these products are not dispensed by a pharmacist and carry no Alabama consumer protections. In 2026 the Board of Medical Examiners issued a notice that no physician may compound, administer, or dispense a non-FDA-approved or research-grade peptide or delegate that to a CRNP, CNM, or PA, and that physicians must buy all prescription products, drugs, and ingredients from entities permitted by the Alabama State Board of Pharmacy. No research-grade peptide is on any approved CRNP, CNM, or PA formulary, and a patient consent form does not remove the provider's liability. [1] [9] [12] [14]

Alabama notes on specific peptides

  • Semaglutide: Available branded from any Alabama pharmacy by prescription, including telehealth prescriptions under sections 34-24-701 through 34-24-707. The Alabama State Board of Pharmacy has stated that compounding with semaglutide sodium or semaglutide acetate is not acceptable, and compounded semaglutide base is limited to the federal patient-specific exception since the 503A grace period ended April 22, 2025. [6] [8] [11]

How to check a clinic in Alabama

  1. Confirm the prescribing clinician's license with the Alabama medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Alabama State Board of Pharmacy license lookup. [1] [2] [3] [4] [5] [8] [10]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Alabama. [1] [9] [12] [14]

Common questions in Alabama

Can I get a GLP-1 prescription in Alabama through telehealth without an in-person visit?

Yes. Under Code of Alabama sections 34-24-701 through 34-24-707, an Alabama-licensed physician can evaluate you and prescribe a non-controlled drug such as semaglutide or tirzepatide by telehealth if the standard of care is met. If the same physician treats you by telehealth more than four times in 12 months for the same unresolved condition, you must be seen in person within 12 months or referred for in-person care. [6] [7]

Can an out-of-state telehealth doctor treat me in Alabama?

Only if that physician holds an Alabama medical license, including a license issued through the Interstate Medical Licensure Compact. Alabama's 2022 telehealth act repealed the old special purpose license and did not create a registration pathway for physicians licensed only in other states. Check the physician on the Board of Medical Examiners license lookup before paying. [6] [7] [13]

All peptide legal questions for Alabama

Sources

  1. [1]Alabama State Board of Pharmacy
  2. [2]Alabama State Board of Pharmacy: statutes and rules (Title 34, Chapter 23 and Administrative Code chapter 680-X-2)
  3. [3]Alabama Administrative Code rule 680-X-2-.07, Mail order prescriptions (nonresident pharmacy registration)
  4. [4]Alabama Administrative Code rule 680-X-2-.19, Parenteral Sterile Therapy (last amended May 15, 2025), accessed 2026-09-22
  5. [5]Alabama Administrative Code rule 680-X-2-.43, Requirements for Compounding (USP-NF standards), accessed 2026-09-22
  6. [6]Code of Alabama section 34-24-703, Duties of physicians providing telehealth medical services (Act 2022-302)
  7. [7]Alabama Board of Medical Examiners: telemedicine and telehealth licensing
  8. [8]Alabama State Board of Pharmacy position on compounded semaglutide (salt forms), hosted by the Board of Medical Examiners
  9. [9]Alabama Board of Medical Examiners: fraudulent activity alert on Ozempic, semaglutide, and tirzepatide
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA